Suchergebnisse - "Kahan, Thomas"

PubPharm (22)

1

Markers of inflammation, endothelial activation, and arterial stiffness in hypertensive heart disease and the effects of treatment : results from the SILVHIA study

enthalten in: Journal of cardiovascular pharmacology | 2013

von Jekell, A. | Malmqvist, K. | Wallén, N. | +2

2

Effects of ivabradine in patients with stable angina receiving β-blockers according to baseline heart rate : an analysis of the ASSOCIATE study

enthalten in: International journal of cardiology | 2013

von Tardif, J. | Ponikowski, P. | Kahan, T. | +1

3

The effects of antihypertensive treatment on the doppler-derived myocardial performance index in patients with hypertensive left ventricular hypertrophy : results from the Swedish irbesartan in left ventricular hypertrophy investigation versus atenolol (SILVHIA)

enthalten in: Echocardiography (Mount Kisco, N.Y.) | 2009

von Liljedahl, S. | Kahan, T. | Lind, L. | +1

4

Efficacy of the I(f) current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy : a 4-month, randomized, placebo-controlled trial

enthalten in: European heart journal | 2009

von Tardif, J. | Ponikowski, P. | Kahan, T. | +101

CommentIn: Eur Heart J. 2009 Mar;30(5):524-5. - PMID 19193673

5

The lifetime cost effectiveness of amlodipine-based therapy plus atorvastatin compared with atenolol plus atorvastatin, amlodipine-based therapy alone and atenolol-based therapy alone : results from ASCOT1

enthalten in: PharmacoEconomics | 2009

von Lindgren, P. | Buxton, M. | Kahan, T. | +6

6

The relationship between the plasma concentration of irbesartan and the antihypertensive response is disclosed by an angiotensin II type 1 receptor polymorphism : results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs. Atenolol (SILVHIA) Trial

enthalten in: American journal of hypertension | 2008

von Kurland, L. | Hallberg, P. | Melhus, H. | +5

7

Myocardial fibrosis and diastolic dysfunction in patients with hypertension : results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA)

enthalten in: Journal of hypertension | 2007

von Müller-Brunotte, R. | Kahan, T. | López, B. | +4

CommentIn: J Hypertens. 2008 Jul;26(7):1497; author reply 1497-9. - PMID 18551029

8

Tissue velocity echocardiography shows early improvement in diastolic function with irbesartan and atenolol therapy in patients with hypertensive left ventricular hypertrophy. Results form the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA)

enthalten in: American journal of hypertension | 2006

von Müller-Brunotte, R. | Kahan, T. | Malmqvist, K. | +2

CommentIn: Am J Hypertens. 2006 Sep;19(9):937-8. - PMID 16942936

9

Irbesartan and atenolol improve diastolic function in patients with hypertensive left ventricular hypertrophy

enthalten in: Journal of hypertension | 2005

von Müller-Brunotte, R. | Edner, M. | Malmqvist, K. | +1

10

Single nucleotide polymorphisms predict the change in left ventricular mass in response to antihypertensive treatment

enthalten in: Journal of hypertension | 2004

von Liljedahl, U. | Kahan, T. | Malmqvist, K. | +4

CommentIn: J Hypertens. 2004 Dec;22(12):2273-5. - PMID 15614020